Annual Total Long Term Liabilities
$11.42 M
-$15.66 M-57.84%
December 31, 2022
Summary
- As of February 10, 2025, PHXM annual total long term liabilities is $11.42 million, with the most recent change of -$15.66 million (-57.84%) on December 31, 2022.
- During the last 3 years, PHXM annual total long term liabilities has fallen by -$3.26 million (-22.22%).
Performance
PHXM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
N/A
September 30, 2023
Summary
- PHXM quarterly total long term liabilities is not available.
Performance
PHXM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PHXM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.8% | - |
| 3 y3 years | -22.2% | - |
| 5 y5 years | +325.8% | - |
PHXM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.8% | at low | ||
| 5 y | 5-year | -62.1% | at low | ||
| alltime | all time | -62.1% | -97.6% |
PHAXIAM Therapeutics SA Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $12.51 M(+9.5%) |
| Dec 2022 | $11.42 M(-57.8%) | $11.42 M(-31.6%) |
| Jun 2022 | - | $16.70 M(-38.3%) |
| Dec 2021 | $27.08 M(-10.2%) | $27.08 M(-5.3%) |
| Jun 2021 | - | $28.58 M(-5.2%) |
| Dec 2020 | $30.15 M(+105.4%) | $30.15 M(+74.1%) |
| Jun 2020 | - | $17.32 M(+18.0%) |
| Dec 2019 | - | $14.68 M(-2.2%) |
| Dec 2019 | $14.68 M(+707.1%) | - |
| Sep 2019 | - | $15.02 M(+33.8%) |
| Jun 2019 | - | $11.22 M(+517.0%) |
| Dec 2018 | - | $1.82 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $1.82 M(-32.2%) | - |
| Jun 2018 | - | $2.26 M(-15.8%) |
| Dec 2017 | $2.68 M(-14.9%) | $2.68 M(-9.7%) |
| Jun 2017 | - | $2.97 M(-5.8%) |
| Dec 2016 | $3.15 M(+1048.9%) | $3.15 M(+901.4%) |
| Jun 2016 | - | $314.80 K(+14.7%) |
| Dec 2015 | $274.40 K(-57.0%) | $274.40 K(+3.5%) |
| Jun 2015 | - | $265.20 K(-58.5%) |
| Dec 2014 | $638.40 K(-45.5%) | $638.40 K(-39.9%) |
| Jun 2014 | - | $1.06 M(-9.3%) |
| Dec 2013 | $1.17 M(-86.8%) | $1.17 M(+0.4%) |
| Jun 2013 | - | $1.17 M(-86.8%) |
| Dec 2012 | $8.85 M | $8.85 M |
FAQ
- What is PHAXIAM Therapeutics SA annual total long term liabilities?
- What is the all time high annual total long term liabilities for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual total long term liabilities year-on-year change?
- What is the all time high quarterly long term liabilities for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual total long term liabilities?
The current annual total long term liabilities of PHXM is $11.42 M
What is the all time high annual total long term liabilities for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual total long term liabilities is $30.15 M
What is PHAXIAM Therapeutics SA annual total long term liabilities year-on-year change?
Over the past year, PHXM annual total long term liabilities has changed by -$15.66 M (-57.84%)
What is the all time high quarterly long term liabilities for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly total long term liabilities is $30.15 M